According to Future Market Insights (FMI), the global prostate cancer market is poised for significant expansion, driven by rising prostate cancer incidence, increasing adoption of precision oncology, growing availability of targeted and immunotherapy treatments, and advancements in biomarker-driven diagnostics. Healthcare systems worldwide are increasingly focusing on early detection,...